RxDoctor Payments Data

Soheila Azghadi, MD

Radiation Oncology · Walnut Creek, CANPI 1952794455

Payments from drug & device makers

$8,613in general payments, 2019–2025

Across 330 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Merck$732
  • Elekta, Inc.$577
  • Johnson & Johnson$389
  • Novartis$384
  • Genentech USA, Inc.$304
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,613100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)42$1,084
Merck27$732
Elekta, Inc.7$577
Johnson & Johnson15$389
Novartis15$384
Genentech USA, Inc.14$304
Takeda Pharmaceuticals U.S.A., Inc.16$220
Sanofi7$204
Pfizer11$201
Eisai Inc.8$195
Incyte Corporation8$176
Telix Pharmaceuticals7$165
Bayer6$161
Karyopharm Therapeutics Inc.7$149
Exelixis Inc.4$148
Novocure Inc.8$146
Astellas Pharma US Inc6$142
Sumitomo Pharma America, Inc.6$136
AbbVie6$130
E.r. Squibb & Sons, L.L.C.1$126
Pharmaessentia USA Corporation5$125
Agios Pharmaceuticals, Inc.5$122
Coherus Oncology, Inc.4$120
Daiichi Sankyo Inc.5$119
Myriad Genetic Laboratories, Inc.5$112
Sobi, Inc4$109
GSK4$108
AVEO Pharmaceuticals, Inc.4$106
Tactile Systems Technology Inc2$104
Boston Scientific4$96
Lilly USA, LLC4$92
Beone Medicines USA, Inc.4$91
Genmab U.S., Inc.3$85
Servier Pharmaceuticals LLC3$83
Silk Road Medical, Inc.1$80
Recordati_rare_diseases_inc.4$76
Geron Corporation2$66
Gilead3$65
Deciphera Pharmaceuticals Inc.2$64
Zap Surgical Systems, Inc.1$57
ADC Therapeutics America, Inc.2$53
Puma Biotechnology, Inc.2$52
Syndax Pharmaceuticals, Inc.2$48
Molli Surgical (US) Inc2$48
Springworks Therapeutics, Inc.2$47
Spectrum Pharmaceuticals Inc.2$41
Jazz Pharmaceuticals Inc.1$39
Palette Life Sciences, Inc.2$39
Pharmacosmos Therapeutics Inc.2$38
Boehringer Ingelheim2$36
Iovance Biotherapeutics, Inc.1$35
Genentech, Inc.1$33
Accord Healthcare, Inc.2$33
Biocon Biologics Inc1$32
Ipsen Biopharmaceuticals, Inc1$31
Fresenius Kabi USA, LLC1$30
Amgen1$29
Octapharma USA, Inc.1$28
Caris MPI, Inc.1$28
Foundation Medicine, Inc.1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,613 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$1,622,049
Medicare patients
180
Services billed
4,642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →